Cap displayed in your preferred currency (USD)
Industries & Sectors
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| United States (Primary) | PRIMARYUSA | Univ | 6,186 | 77,579,614 | 0.91% | 1.75% | 8.92% | 3.13% | 4.29% | 28.26% |
| Healthcare | HEALTHCARE | Sector | 1,150 | 6,871,123 | 0.35% | -0.77% | 2.76% | -5.87% | 3.68% | 15.41% |
| Biopharmaceuticals | BIOPHARMA | SubSec | 587 | 3,718,924 | 0.25% | -1.32% | 1.98% | -2.22% | 15.01% | 35.00% |
| System-Specific Biopharmaceuticals | BIOPHARMASYS | Industry | 276 | 1,468,632 | 1.53% | 0.84% | 4.59% | -7.60% | 12.04% | 27.86% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 159,674 | 1.19% | 1.17% | 12.43% | 9.33% | 25.74% | 63.20% |
Show Stocks
Sort: 1Mo %
| Description | Symbol | Type | #Stocks | Cap (M) | 1Day %* | 1Wk %* | 1Mo %* | 3Mo %* | 6Mo %* | 1Yr %* |
|---|---|---|---|---|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. | MPLT:USAMPLT:USA | Stock | 1 | 1,402 | 16.33% | 19.44% | 88.11% | 72.93% | N/A | N/A |
| Soleno Therapeutics, Inc. | SLNO:USASLNO:USA | Stock | 1 | 2,782 | 0.11% | 0.34% | 66.30% | 20.57% | -21.42% | -26.12% |
| Taysha Gene Therapies, Inc. | TSHA:USATSHA:USA | Stock | 1 | 1,930 | 8.04% | 12.00% | 48.02% | 32.02% | 30.49% | 277.53% |
| GH Research PLC | GHRS:USAGHRS:USA | Stock | 1 | 1,175 | -8.23% | 11.47% | 43.45% | 13.20% | 48.51% | 101.38% |
| Alto Neuroscience, Inc. | ANRO:USAANRO:USA | Stock | 1 | 844 | 6.14% | 6.64% | 35.66% | 58.09% | 150.32% | >999.99% |
| LB Pharmaceuticals, Inc. | LBRX:USALBRX:USA | Stock | 1 | 911 | 0.00% | 9.13% | 34.26% | 34.78% | 98.63% | N/A |
| Rapport Therapeutics, Inc. | RAPP:USARAPP:USA | Stock | 1 | 1,696 | -0.46% | 0.19% | 31.78% | 31.73% | 37.34% | 218.44% |
| Design Therapeutics, Inc. | DSGN:USADSGN:USA | Stock | 1 | 825 | 0.60% | 4.86% | 31.47% | 25.89% | 137.48% | 237.63% |
| Arrowhead Pharmaceuticals, Inc. | ARWR:USAARWR:USA | Stock | 1 | 10,351 | 4.04% | 4.19% | 30.44% | 6.22% | 94.37% | 498.06% |
| Definium Therapeutics, Inc. | DFTX:USADFTX:USA | Stock | 1 | 2,274 | -3.19% | 4.20% | 27.51% | 36.00% | 82.59% | 297.93% |
| Bright Minds Biosciences, Inc. | DRUG:USADRUG:USA | Stock | 1 | 882 | 3.12% | 0.59% | 24.40% | -0.27% | 29.84% | 169.10% |
| Biohaven Ltd. | BHVN:USABHVN:USA | Stock | 1 | 1,551 | 4.81% | 2.99% | 22.20% | -22.38% | -39.76% | -49.50% |
| Alkermes Plc | ALKS:USAALKS:USA | Stock | 1 | 5,571 | 0.66% | 1.57% | 21.76% | -0.62% | 7.28% | 24.46% |
| Prothena Corp. Plc | PRTA:USAPRTA:USA | Stock | 1 | 577 | 0.47% | -0.92% | 21.54% | 3.68% | 4.94% | 12.37% |
| Axsome Therapeutics, Inc. | AXSM:USAAXSM:USA | Stock | 1 | 9,179 | 1.89% | 1.22% | 18.86% | -0.30% | 41.88% | 79.56% |
| Solid Biosciences, Inc. | SLDB:USASLDB:USA | Stock | 1 | 826 | 2.94% | 0.96% | 17.65% | 22.45% | 39.77% | 144.90% |
| Annexon, Inc. | ANNX:USAANNX:USA | Stock | 1 | 1,005 | 0.97% | -1.42% | 16.57% | -10.06% | 100.00% | 255.68% |
| Sarepta Therapeutics, Inc. | SRPT:USASRPT:USA | Stock | 1 | 2,163 | -0.19% | -5.02% | 16.54% | -5.28% | -11.61% | -65.20% |
| Capricor Therapeutics, Inc. | CAPR:USACAPR:USA | Stock | 1 | 2,013 | -0.96% | -0.11% | 16.28% | 44.81% | 449.45% | 151.98% |
| Harmony Biosciences Holdings, Inc. | HRMY:USAHRMY:USA | Stock | 1 | 1,841 | -0.53% | 9.41% | 15.83% | -13.03% | 22.21% | 9.56% |
| Dianthus Therapeutics, Inc. | DNTH:USADNTH:USA | Stock | 1 | 4,971 | 1.26% | -4.67% | 15.09% | 73.03% | 160.61% | 317.42% |
| Praxis Precision Medicines, Inc. | PRAX:USAPRAX:USA | Stock | 1 | 9,244 | -1.04% | -0.78% | 14.68% | 10.81% | 77.50% | 837.44% |
| Neurology Biopharmaceuticals | NEUROLOGY | SubInd | 90 | 159,674 | 1.19% | 1.17% | 12.43% | 9.33% | 25.74% | 63.20% |
| Catalyst Pharmaceuticals, Inc. | CPRX:USACPRX:USA | Stock | 1 | 3,168 | 1.17% | 0.35% | 11.23% | 6.09% | 21.05% | 14.78% |
| Jazz Pharmaceuticals Plc | JAZZ:USAJAZZ:USA | Stock | 1 | 12,474 | 1.69% | 1.54% | 11.01% | 18.36% | 47.20% | 95.78% |
| Dyne Therapeutics, Inc. | DYN:USADYN:USA | Stock | 1 | 3,183 | 2.39% | -1.55% | 10.07% | 8.79% | 17.43% | 98.49% |
| S&P 500 | SPY:USASPY:USA | Benchmark | 14,116 | 102,963,328 | 1.01% | 1.61% | 8.52% | 3.51% | 6.55% | 36.44% |
| Scholar Rock Holding Corp. | SRRK:USASRRK:USA | Stock | 1 | 5,437 | -1.60% | -4.03% | 8.41% | -0.90% | 68.02% | 49.59% |
| Edgewise Therapeutics, Inc. | EWTX:USAEWTX:USA | Stock | 1 | 3,451 | -0.86% | -4.54% | 7.95% | 8.03% | 107.41% | 137.77% |
| Stoke Therapeutics, Inc. | STOK:USASTOK:USA | Stock | 1 | 2,051 | 0.81% | 1.01% | 7.49% | 19.47% | 3.52% | 289.37% |
| PTC Therapeutics, Inc. | PTCT:USAPTCT:USA | Stock | 1 | 5,615 | 0.31% | -3.70% | 6.67% | -6.98% | 5.48% | 47.02% |
| ACADIA Pharmaceuticals, Inc. | ACAD:USAACAD:USA | Stock | 1 | 3,752 | 2.02% | 2.21% | 5.96% | -19.16% | 4.56% | 54.98% |
| Xenon Pharmaceuticals, Inc. | XENE:USAXENE:USA | Stock | 1 | 5,406 | 0.44% | -3.79% | 4.10% | 34.11% | 31.62% | 54.23% |
| Biogen, Inc. | BIIB:USABIIB:USA | Stock | 1 | 27,867 | 2.22% | 5.28% | 3.50% | 9.36% | 29.99% | 59.87% |
| Neurocrine Biosciences, Inc. | NBIX:USANBIX:USA | Stock | 1 | 13,079 | 0.74% | -0.20% | 3.25% | -4.51% | -8.04% | 28.94% |
| Supernus Pharmaceuticals, Inc. | SUPN:USASUPN:USA | Stock | 1 | 2,884 | 2.38% | 0.70% | 2.11% | 2.42% | -0.75% | 63.07% |
* Colors indicate performance relative to the benchmark.